Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionJustInvest LLC
Latest Disclosed Ownership41,623 shares
Latest Disclosed Value $ 18,586,334
JustInvest LLC reports 6.28% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 14, 2026 - JustInvest LLC filed a 13F-HR form disclosing ownership of 41,623 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $18,586,334 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 39,165 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 6.28% during the quarter. The current value of the position is $18,598,405 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 41,623 2,458 6.28 18,586 4.68 0.1824
2026-02-13 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 39,165 2,165 5.85 17,756 22.52 0.1732
2025-10-31 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 37,000 -1,491 -3.87 14,492 -15.44 0.1484
2025-07-25 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 38,491 2,729 7.63 17,138 -1.15 0.1934
2025-05-14 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 35,762 4,584 14.70 17,338 38.09 0.2557
2025-02-10 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 31,178 -619 -1.95 12,555 -15.10 0.1896
2024-11-12 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 31,797 2,340 7.94 14,788 8.05 0.2381
2024-08-12 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 29,457 4,470 17.89 13,686 31.04 0.2606
2024-05-09 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 24,987 909 3.78 10,445 6.60 0.2242
2024-02-08 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 24,078 -1,677 -6.51 9,797 9.40 0.2542
2023-11-08 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 25,755 1,495 6.16 8,956 4.90 0.2677
2023-07-28 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 24,260 1,884 8.42 8,537 21.09 0.2615
2023-05-10 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 22,376 1,681 8.12 7,050 17.97 0.2449
2023-02-10 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 20,695 531 2.63 5,976 2.36 0.2466
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 20,164 1,450 7.75 5,838 10.71 0.2640
2022-08-12 2022-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 18,714 4,809 34.58 5,273 45.30 0.2442
2022-08-09 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 18,714 4,809 5,273 0.2442
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 13,905 3,410 32.49 3,629 57.44 0.1757
2022-02-23 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 10,495 5,739 120.67 2,305 167.09 0.1358
2021-11-09 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,756 2,235 88.66 863 69.88 0.0775
2021-08-11 2021-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,521 -1,749 -40.96 508 -44.66 0.0532
2021-07-21 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,270 0 918 0.1397
2021-04-28 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,270 1,216 39.82 918 27.15 0.1390
2021-01-20 2020-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 3,054 -50 -1.61 722 -14.56 0.1571
2020-10-26 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,104 1,416 83.89 845 72.45 0.2371
2020-07-27 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,688 471 38.70 490 68.97 0.2223
2020-05-13 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,217 1,217 290 0.1691
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.